<?xml version='1.0' encoding='utf-8'?>
<document id="28249566"><sentence text="Positive-Unlabeled Learning for inferring drug interactions based on heterogeneous attributes." /><sentence text="Investigating and understanding drug-drug interactions (DDIs) is important in improving the effectiveness of clinical care" /><sentence text=" DDIs can occur when two or more drugs are administered together" /><sentence text=" Experimentally based DDI detection methods require a large cost and time" /><sentence text=" Hence, there is a great interest in developing efficient and useful computational methods for inferring potential DDIs" /><sentence text=" Standard binary classifiers require both positives and negatives for training" /><sentence text=" In a DDI context, drug pairs that are known to interact can serve as positives for predictive methods" /><sentence text=" But, the negatives or drug pairs that have been confirmed to have no interaction are scarce" /><sentence text=" To address this lack of negatives, we introduce a Positive-Unlabeled Learning method for inferring potential DDIs" /><sentence text="" /><sentence text="The proposed method consists of three steps: i) application of Growing Self Organizing Maps to infer negatives from the unlabeled dataset; ii) using a pairwise similarity function to quantify the overlap between individual features of drugs and iii) using support vector machine classifier for inferring DDIs" /><sentence text=" We obtained 6036 DDIs from DrugBank database" /><sentence text=" Using the proposed approach, we inferred 589 drug pairs that are likely to not interact with each other; these drug pairs are used as representative data for the negative class in binary classification for DDI prediction" /><sentence text=" Moreover, we classify the predicted DDIs as Cytochrome P450 (CYP) enzyme-Dependent and CYP-Independent interactions invoking their locations on the Growing Self Organizing Map, due to the particular importance of these enzymes in clinically significant interaction effects" /><sentence text=" Further, we provide a case study on three predicted CYP-Dependent DDIs to evaluate the clinical relevance of this study" /><sentence text="" /><sentence text="Our proposed approach showed an absolute improvement in F1-score of 14 and 38% in comparison to the method that randomly selects unlabeled data points as likely negatives, depending on the choice of similarity function" /><sentence text=" We inferred 5300 possible CYP-Dependent DDIs and 592 CYP-Independent DDIs with the highest posterior probabilities" /><sentence text=" Our discoveries can be used to improve clinical care as well as the research outcomes of drug development" /><sentence text="" /></document>